Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      US to wrap criminal trial of Insys Therapeutics

      US to wrap criminal trial of Insys Therapeutics' executives tied to opioid crisis

      Medical Dialogues Bureau6 April 2019 8:59 AM IST
      BOSTON: Prosecutors on Thursday will present their closing arguments in the trial of the wealthy founder of pharmaceutical company Insys Therapeutics...
      USFDA takes action to combat illegal online sale of opioids including Tramadol

      USFDA takes action to combat illegal online sale of opioids including Tramadol

      Medical Dialogues Bureau5 April 2019 9:15 AM IST
      U.S: The U.S. Food and Drug Administration(USFDA) recently announced the issuance of two warning letters to operators of websites that illegally...
      Novartis division Alcon spinoff ousts Baer from Swiss benchmark SMI

      Novartis division Alcon spinoff ousts Baer from Swiss benchmark SMI

      Medical Dialogues Bureau5 April 2019 9:00 AM IST
      Novartis has estimated Alcon's value at around 25 billion Swiss francs ($25 billion), while some analysts predict an initial market capitalisation of...
      Family behind OxyContin calls opioid suit false, misleading

      Family behind OxyContin calls opioid suit false, misleading

      Medical Dialogues Bureau4 April 2019 9:04 AM IST
      BOSTON: Massachusetts authorities created a false picture of the Sackler family's role in promoting OxyContin, the Sacklers said Tuesday in their...
      Cigna caps insulin prices at $25 for 30 days

      Cigna caps insulin prices at $25 for 30 days

      Medical Dialogues Bureau4 April 2019 9:00 AM IST
      Cigna, which bought pharmacy benefits manager Express Scripts last year, said it was partnering with insulin manufacturers to lower copayments to $25...
      China to regulate all fentanyl drugs as controlled substance

      China to regulate all fentanyl drugs as controlled substance

      Medical Dialogues Bureau3 April 2019 9:00 AM IST
      China already controls more than two dozen variants of fentanyl, plus two precursors. Data from the U.S. Drug Enforcement Administration has shown...
      US Government boosts 2020 Medicare payments to insurers by 2.53 percent

      US Government boosts 2020 Medicare payments to insurers by 2.53 percent

      Medical Dialogues Bureau3 April 2019 8:59 AM IST
      NEW YORK: The U.S. government on Monday said it would increase by 2.53 per cent on average 2020 payments to the health insurers that manage Medicare...
      Bayer CEO defends Monsanto deal amid Roundup rulings

      Bayer CEO defends Monsanto deal amid Roundup rulings

      Medical Dialogues Bureau1 April 2019 9:00 AM IST
      Bayer, which denies allegations that glyphosate or Roundup cause cancer, acquired Monsanto, the maker of Roundup, for $63 billion last year.U.S:...
      Hawaii eyes flavored e-cigarette ban to curb teen vaping

      Hawaii eyes flavored e-cigarette ban to curb teen vaping

      Medical Dialogues Bureau31 March 2019 9:14 AM IST
      The proposal would ban flavoured e-cigarette liquids such as Maui Mango and Cookie Monsta, along with cloves and other flavoured tobacco products, but...
      New Jersey lawmakers near vote on recreational cannabis

      New Jersey lawmakers near vote on recreational cannabis

      Medical Dialogues Bureau31 March 2019 9:00 AM IST
      The measure calls for setting up a five-person cannabis regulatory commission, which would set the ground rules and oversee marijuana regulation in...
      Hiranandani Parks Hospital Commences Operations as a 30 Bedded Multi-Specialties Hospital

      Hiranandani Parks Hospital Commences Operations as a 30 Bedded Multi-Specialties Hospital

      Medical Dialogues Bureau29 March 2019 4:21 PM IST
      Chennai: Hiranandani Parks Hospital has announced that it will also offer healthcare facilities with best global practices at the Hiranandani Parks...
      Cancer Causing Talcum Powder: JnJ gets New Jersey jury relief

      Cancer Causing Talcum Powder: JnJ gets New Jersey jury relief

      Medical Dialogues Bureau29 March 2019 11:40 AM IST
      JnJ on Wednesday also settled three other mesothelioma talc cases pending in state courts in California, Oklahoma and New York, Chris Panatier, a...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok